Creative Planning

Position in EOLS — Evolus, Inc.

CIK 1540235 OVERLAND PARK, KS

Position in EOLS

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$118,109

-$41,890 QoQ

Shares Held

28,737

+19.4% QoQ

Ownership

0.044%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 1% Shared 0% None 99%

Healthcare · as of Mar 31, 2026

Creative Planning holds $105,843,094 across 40 Drug Manufacturers - Specialty & Generic names. EOLS ranks #36 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RDY	Dr Reddys Laboratories Ltd	1,167,182	$16,165,470
2	UTHR	UNITED THERAPEUTICS Corp	22,075	$13,090,033
3	VTRS	Viatris Inc	770,971	$10,415,817
4	TAK	Takeda Pharmaceutical Co Ltd	542,996	$10,056,285
5	ZTS	Zoetis Inc.	77,690	$9,183,734
6	NBIX	Neurocrine Biosciences Inc	68,387	$9,009,303
7	HLN	Haleon plc	630,997	$6,316,279
8	LNTH	Lantheus Holdings, Inc.	80,292	$6,090,147

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$118,109	28,737	+19.4%	Shares	Sole	2026-05-12
2025-12-31	$159,999	24,060	+6.7%	Shares	Sole	2026-02-17
2025-09-30	$138,449	22,549	+110.4%	Shares	Defined	2025-11-14
2025-03-31	$128,913	10,716	-22.0%	Shares	Sole	2025-05-15
2024-12-31	$151,612	13,733	-11.1%	Shares	Sole	2025-02-14
2024-09-30	$250,306	15,451	+23.7%	Shares	Sole	2024-10-11
2024-06-30	$135,494	12,488	+24.3%	Shares	Sole	2024-08-15
2021-12-31	$65,399	10,046	-8.2%	Shares	Sole	2022-02-11
2021-06-30	$138,466	10,946	-61.2%	Shares	Sole	2021-08-04
2021-03-31	$366,330	28,201	-4.8%	Shares	Sole	2021-04-30
2020-12-31	$99,536	29,624	+9.8%	Shares	Sole	2021-01-29
2020-09-30	$105,483	26,978	+0.0%	Shares	Sole	2020-11-05
2020-06-30	$142,930	26,968	+9.1%	Shares	Sole	2020-07-23
2020-03-31	$102,600	24,723	—	Shares	Sole	2020-05-05
No filing history on record for this holder in this stock.